As of June 2025 Sino Biopharmaceutical has a market cap of โฌ9.83 Billion. This makes Sino Biopharmaceutical the world's 1624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ9.83 B | 35.05% |
2024 | โฌ7.28 B | -3.67% |
2023 | โฌ7.55 B | -27% |
2022 | โฌ10.35 B | -11.11% |
2021 | โฌ11.64 B | -22.02% |
2020 | โฌ14.93 B | -5.04% |
2019 | โฌ15.72 B | 116.59% |
2018 | โฌ7.26 B | -33.71% |
2017 | โฌ10.95 B | 120.77% |
2016 | โฌ4.96 B | -19.65% |
2015 | โฌ6.17 B | 67.68% |
2014 | โฌ3.68 B | 29.76% |
2013 | โฌ2.83 B | 59.14% |
2012 | โฌ1.78 B | 57.68% |
2011 | โฌ1.13 B | -18.28% |
2010 | โฌ1.38 B | 35.81% |
2009 | โฌ1.01 B | 363.08% |
2008 | โฌ0.22 B | -23.69% |
2007 | โฌ0.28 B | 42.01% |
2006 | โฌ0.20 B | -48.19% |
2005 | โฌ0.39 B | 89.88% |
2004 | โฌ0.20 B |